Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local Level
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology China
    Real-World Evidence of SUL-DUR on Special Populations with CRAB Infection
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Optimizing Adult Vaccination Ecosystem in India
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Vaccines India
    Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator Therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Innovative digital educational channels in Oncology for health care professionals or patients to increase local awareness
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Spain
    Individualized Menopause Care
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Approaches to Improve Delivery of Quality of Care for Patients with Inflammatory, and Immune Skin Diseases
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Japan
    Promoting Appropriate Diagnosis and Treatment of Migraine Care
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Burden of RSV Disease - Analyzing Local Surveillance Data for Older Adults (EM Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Improving Education Disparities of Non-Specialized Health Care Providers to Deliver Appropriate Medical Care for IBD Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Argentina, Brazil, India, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates
    Increasing Understanding of the Evolving Hemophilia Treatment Landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Non-Muscle Invasive Bladder Cancer Emerging Markets Needs Assessment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Argentina, Brazil, Colombia, Hong Kong, India, Mexico, Saudi Arabia, Taiwan, Turkey, United Arab Emirates
    Addressing Educational Barriers to Equitable Care for Patients with Immune Inflammatory Diseases
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Juvenile Idiopathic Arthritis (JIA) Patient Education
    Release Date:
    Review Process: Expert Review Panel
    Education Inflammation & Immunology USA
    Updates on RSV in Older Adults for Pharmacists
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    PARP-inhibitor Combination Treatments in Prostate Cancer, a Global Perspective
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All